By Sheri Kasprzak
Atlanta, Dec. 3 - Novamex USA Ltd. said Friday it has issued $2 million in a convertible subordinated debenture.
The debenture bears interest at 10.05% per year and is convertible into common shares at $0.40 each for five years.
The debenture matures Nov. 30, 2009.
Novamex may redeem the debenture or any unconverted portion at 110% of the face value after Nov. 30, 2006.
The first closing of the transaction is scheduled for Dec. 7.
Based in Ville Saint-Laurent, Quebec, Novamex is a biotechnology company focusing on the diagnosis of Mad Cow Disease. The company plans to use the funds from the financing to accelerate the development of its antigen-antibody test for Mad Cow Disease and to evaluate potential acquisitions.
| Issuer: | Novamex USA Ltd.
|
| Issue: | Convertible subordinated debentures
|
| Amount: | $2 million
|
| Maturity: | Nov. 30, 2009
|
| Coupon: | 10.05%
|
| Conversion price: | $0.40
|
| Call: | Callable at 110% of face value after Nov. 30, 2006
|
| Warrants: | No
|
| Pricing date: | Nov. 30
|
| Settlement date: | Dec. 7
|
| Stock price: | $0.18 at close Nov. 30
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
